Table 2.

Patient characteristics, CO-RADS classification, and extra-thoracic sites with increased FDG uptake during the corresponding period of 2019

	Sex	Age (year)	Disease	Phase	Symptoms	Treatment	CO-RADS	Extra-thoracic sites with FDG uptake
1	M	72	Oral cavity cancer	Follow-up	None	Chemotherapy, radiation therapy	4	Mediastinal and abdominal LN
2	F	58	Gastric cancer	Staging	None	None	2	Neck, mediastinal, mesenteric and pelvic LN, liver, bone
3	M	78	Suspected lung cancer	Diagnosis	None	None	4	Mediastinal LN, bone
4	M	76	Lung cancer	Staging	Cough, dyspnea	None	3	Bone
5	M	67	Lung cancer	Follow-up	None	Surgery, chemotherapy	3	None
6	M	59	Non-Hodgkin lymphoma	Follow-up	None	Chemotherapy	3	Neck LN
7	M	70	Suspected mediastinal tumor	Diagnosis	None	None	4	None
8	M	15	Sarcoma	Staging	None	None	3	Bone
9	F	41	Thymoma	Staging	Cough, dyspnea, chest pain	None	5	Bone, pituitary gland
10	F	60	Lung cancer	Follow-up	None	Immunotherapy	3	Neck, axillary and mediastinal LN, adrenal gland
11	M	46	Non-Hodgkin lymphoma	Follow-up	None	Chemotherapy	2	Neck LN
12	M	60	Multiple myeloma	Follow-up	Cough, dyspnea	Chemotherapy, bone marrow transplantation	2	Bone
13	M	77	Endocarditis	Diagnosis	None	None	5	Mediastinal LN
14	F	91	Fever of unknown origin	Diagnosis	Cough, dyspnea	None	3	Bone

F, female; LN, lymph node uptake; M, male